drugset / Trial / NCT05968430
Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study is to evaluate the long-term safety, efficacy and tolerability of lorundrostat (an aldosterone synthase inhibitor) in subjects with hypertension
Timeline
- Start
- 2023-07-14
- Primary completion
- 2025-12-30
- Completion
- 2027-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | lorundrostat | Small molecule | — | Oral |